sb 216763 has been researched along with Akinetic-Rigid Variant of Huntington Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexander, J; Aronin, N; Chase, K; DiFiglia, M; Kegel, KB; Li, X; Reeves, PB; Sapp, E; Valencia, A | 1 |
| Bao, YP; Carmichael, J; Rubinsztein, DC; Sugars, KL | 1 |
2 other study(ies) available for sb 216763 and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease.
Topics: Analysis of Variance; Animals; Blotting, Western; Cell Fractionation; Cell Survival; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Glycogen Synthase Kinase 3; Huntingtin Protein; Huntington Disease; Indoles; Maleimides; Membrane Microdomains; Mice; Mice, Transgenic; Microscopy, Confocal; Nerve Degeneration; Nerve Tissue Proteins; Neurons; Nuclear Proteins | 2010 |
Glycogen synthase kinase-3beta inhibitors prevent cellular polyglutamine toxicity caused by the Huntington's disease mutation.
Topics: Animals; beta Catenin; Cell Aggregation; Cell Death; COS Cells; Cytoskeletal Proteins; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Heat-Shock Proteins; HSP27 Heat-Shock Proteins; HSP70 Heat-Shock Proteins; Humans; Huntington Disease; Indoles; Lithium Chloride; Maleimides; Molecular Chaperones; Mutation; Neoplasm Proteins; Peptides; Proto-Oncogene Proteins c-bcl-2; Trans-Activators; Transcription, Genetic; Tumor Cells, Cultured | 2002 |